Primary Hypertension
Showing 1 - 25 of >10,000
Hypertension Trial in Shantou, Taiyuan, Tianjin (FMT capsules, Placebo capsules)
Not yet recruiting
- Hypertension
- FMT capsules
- Placebo capsules
-
Shantou, Guangdong, China
- +2 more
Nov 1, 2022
Essential Hypertension, Primary Hypertension Trial (Amicomed®, Digital Placebo, Usual Care)
Not yet recruiting
- Essential Hypertension
- Primary Hypertension
- Amicomed®
- +2 more
- (no location specified)
Oct 19, 2023
Pediatric Primary Hypertension and Renin-Angiotensin System
Active, not recruiting
- Pediatric Disorder
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Medical Center
Aug 5, 2022
Hypertension, Blood Pressure, Cardiovascular Diseases Trial in Winston-Salem (HIRREM, Continued Current Care)
Active, not recruiting
- Hypertension
- +4 more
- HIRREM
- Continued Current Care
-
Winston-Salem, North CarolinaDepartment of Neurology, Wake Forest School of Medicine
Jul 28, 2022
Primary Hypertension Trial in Sleman (MaRiTensi App)
Not yet recruiting
- Primary Hypertension
- MaRiTensi App
-
Sleman, DI Yogyakarta, IndonesiaPuskesmas Pakem
Sep 16, 2023
Eye Movement Desensitization and Reprocessing Intervention, Blood Pressure, Heart Rate Variability Trial in Taipei (Eye Movement
Completed
- Eye Movement Desensitization and Reprocessing Intervention
- +3 more
- Eye Movement Desensitization and Reprocessing
-
Taipei, Neihu, TaiwanChen, miao-yi
Apr 18, 2023
Primary Aldosteronism in Hypertension With 24-hour URinary
Recruiting
- Hypertension
- +2 more
-
Cambridge, United KingdomVascular Research Clinic, Adenbrooke's Centre of Clinical Invest
Sep 15, 2023
Primary Hypertension Trial in Chongqing (External Ultrasonic Micro-bubble)
Not yet recruiting
- Primary Hypertension
- External Ultrasonic Micro-bubble
-
Chongqing, Chongqing, ChinaThe Second Affilated Hospital of Chongqing Medical Universty
Oct 30, 2023
Primary Aldosteronism, Resistant Hypertension, Secondary Hypertension Trial in Boston (Best Practice Advisory Computerized
Not yet recruiting
- Primary Aldosteronism
- +5 more
- Best Practice Advisory Computerized Alert
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 22, 2023
Diabetes, Type 2, Hypertension, Cardiovascular Diseases Trial (Integrated Diabetes and Hypertension Primary Care Model,
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Integrated Diabetes and Hypertension Primary Care Model
- Integrated Diabetes and Hypertension Primary Care Model - Providers
- (no location specified)
Oct 6, 2023
Community-based Primary Care Program Effects on Pharmacotherapy
Completed
- Type 2 Diabetes
- Hypertension
- community-based primary care program
- (no location specified)
Jul 30, 2023
Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)
Not yet recruiting
- Essential Hypertension
- Primary Hypercholesterolemia
- Fimasartan
- +3 more
-
Seoul, Korea, Republic ofSeverance Hospital
Jun 26, 2023
Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial
Not yet recruiting
- Primary Open Angle Glaucoma (POAG)
- +3 more
- Experimental: QLS-111 ophthalmic solution, (0.015%)
- +4 more
- (no location specified)
Aug 30, 2023
Ocular Hypertension, Primary Open Angle Glaucoma Trial in Lackland Air Force Base (Nanodropper, Regular dropper)
Recruiting
- Ocular Hypertension
- Primary Open Angle Glaucoma
- Nanodropper
- Regular dropper
-
Lackland Air Force Base, TexasWilford Hall Ambulatory Surgical Center
May 3, 2023
Hypertension, Physical Activity, Dietary Habits Trial (DASH-ExMAMI)
Not yet recruiting
- Hypertension
- +4 more
- DASH-ExMAMI
- (no location specified)
Nov 25, 2023
Primary Hypertension Trial in Nanchang (Heat-sensitive moxibustion plus original antihypertensive treatment (compulsively
Active, not recruiting
- Primary Hypertension
- Heat-sensitive moxibustion plus original antihypertensive treatment (compulsively randomized arm)
- +5 more
-
Nanchang, Jiangxi, China
- +6 more
Jan 17, 2022
Glaucoma Open-Angle Primary, Ocular Hypertension Trial in Albany (H-1337 0.6%, H-1337 1.0%, H-1337 Placebo)
Not yet recruiting
- Glaucoma Open-Angle Primary
- Ocular Hypertension
- H-1337 0.6%
- +3 more
-
Albany, GeorgiaDixon Eye Care
Jun 12, 2023
Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn
Recruiting
- Hyperaldosteronism
- +7 more
- Skin Biopsy
- Video-laparoscopic adrenalectomy
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 23, 2023
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
Diabetes, Hypertension Trial (PEN, ePEN)
Recruiting
- Diabetes Mellitus
- Hypertension
- DSD
- CDP
-
Mbabane, SwazilandClinton Health Access Initiative
Dec 12, 2022
d Plasma Volume in Pulmonary Hypertension
Completed
- Pulmonary Arterial Hypertension
- +2 more
- (no location specified)
May 5, 2023
Hypertension Trial in China (Probiotic powder, Placebo powder)
Recruiting
- Hypertension
- Probiotic powder
- Placebo powder
-
Beijing, Beijing, China
- +6 more
Dec 30, 2021
Pulmonary Arterial Hypertension Trial in Peshawar (Supervised endurance exercise training + Patient Education, Home exercises +
Not yet recruiting
- Pulmonary Arterial Hypertension
- Supervised endurance exercise training + Patient Education
- Home exercises + Patient Education
-
Peshawar, Khyber Pakhtunkhwa, Pakistan
- +1 more
Jul 7, 2023
Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo
Recruiting
- Hypertension
- +8 more
- Tamoxifen
- Placebo Oral Tablet
-
Nashville, TennesseeVanderbilt University Medical Center
Aug 22, 2022